Dr. Anthony Rossi is a Mohs surgeon at Memorial Sloan Kettering, where he treats thousands of cancer patients with skin left raw and inflamed by treatment. He could not find a skincare line that was both medical-grade and genuinely clean enough for them. So he built one, around a single idea: that chronic inflammation is what ages skin.
Dr. Rossi DERM MD did not come out of a beauty lab. It came out of a cancer hospital. Dr. Anthony Rossi is a board-certified dermatologist and Mohs surgeon at Memorial Sloan Kettering, the premier cancer center in the United States, where a lot of his work is on skin that has been pushed to its absolute limit.
Many of his patients are going through cancer therapies that leave their skin extremely sensitive, raw and inflamed. Day after day, Rossi was trying to care for the most reactive skin imaginable, and kept hitting the same wall: there was no skincare that was both serious enough to be medical-grade and clean enough to be safe for people that fragile.
He was a skin doctor who could not find skincare good enough for his own patients. So the problem became his.
Working with that fragile skin led Rossi to an insight that became the whole brand. Searching for effective age-defying care, he came to believe that calming skin sensitization, the chronic, low-grade inflammation underneath, could itself help address the visible signs of premature aging. He calls it inflammatory aging: the idea that inflammation is not a side issue in how skin ages, it is the engine.
The science is specific. Rossi's work centers on the TRPV1 receptor, which gets unnecessarily triggered, driving sensitivity and the overproduction of an enzyme that breaks down collagen. Build a product that quiets that signal, and you are treating sensitivity and aging at the same root, instead of papering over them separately.
Most skincare makes you pick a side. You can have clinical, dermatologist-strength actives, or you can have a clean, gentle formula, but rarely both in the same bottle. Rossi's patients did not have the luxury of choosing, they needed something potent enough to work and gentle enough not to flare already-damaged skin. So he formulated for both at once.
And he built it for everyone, not just the people in his clinic. The line is designed to work regardless of age, gender, complexion or how sensitive your skin runs, because the underlying problem he is treating, inflammation, is universal. What started as a fix for cancer patients became a brand for anyone whose skin reacts to everything.
The Catalyst, the serum at the center of the line, built on Rossi's inflammatory-aging science and packaged with the restraint of something that belongs on a doctor's shelf, not a vanity. It is the clearest expression of the brand: medical-grade actives in a formula clean enough for the most sensitive skin he treats.
Building this was not a side hobby for a doctor with spare time. Rossi did it while keeping a full surgical practice at one of the most demanding cancer centers in the country, and unlike the many physician-branded lines that license a name to a contract formulator, he stayed in the formulation himself. To get the chemistry he wanted, the line was developed in Seoul, leaning on Korean formulation technique while stripping out the ingredients that flare reactive skin. A working Mohs surgeon learning a consumer-products supply chain on the side is its own kind of hard.
The deeper tradeoff is the one in every bottle. Clinical strength and a genuinely clean, low-sensitivity formula usually pull in opposite directions, and refusing to pick a side means a slower, more constrained build than a brand that simply maximizes one of them. Rossi frames the science around calming inflammation as his clinical thesis, not a cure-all, and the company now has to prove that thesis to shoppers who are not his patients. Independent retail is the early read on whether it travels: the line is carried at Ulta Beauty and Nordstrom, well outside the walls of the clinic where the idea started.
Dr. Rossi DERM MD, in five moments
The arc
What makes Dr. Rossi DERM MD different from the usual doctor-on-the-box brand is the order it was built in. Rossi did not spot a market and reverse-engineer credibility into it, he ran into a clinical problem in front of his most fragile patients, formed a thesis about inflammation he could defend, and only then made a product to test it. Formulating for the hardest case first is slow and unforgiving, and it is also why a line built for skin recovering from cancer ended up gentle enough, and serious enough, to work on almost anyone.
We profile the operators behind the brands we admire, how they started, what they got right, and what made them durable. Reported like a feature, not a pitch.
Read more stories